Emerging tools now afford the ability to purposefully engineer living organisms for specific intent, enhanced by the convergence of biotechnologies with machine learning and artificial intelligence. In addition to technological advancements is the adoption and use of these capabilities by commercial industry in support of a growing “biotechnological revolution,” or “bioeconomy.” Many biotechnology innovations in the bioeconomy exist in distinct sectors from the traditional sectors of health and agriculture, which creates biosecurity challenges. This also means that biology is being engineered by individuals and entities outside traditional biological disciplines and training. These new aspects of the biotechnology landscape come with novel biosecurity risks that go beyond the scope of traditional biosecurity.
Click here to read more →